Milk and Dairy Consumption and Its Relationship With Abundance of Lactobacillus crispatus in the Vaginal Microbiota: Milk Intake and Vaginal Lactobacillus
- 2023-04-11
- Journal of Lower Genital Tract Disease 27(3)
- Gabriela B Moura
- Márcia G Silva
- C. Marconi
- PubMed: 37043391
- DOI: 10.1097/LGT.0000000000000736
Abstract
Objectives: Diet habits, such as low milk and dairy intake, have been associated with bacterial vaginosis. Thus, the authors compared vaginal Lactobacillus crispatus abundances in women with different molecularly defined community state types (CSTs) according to the consumption of milk and/or dairy products.
Methods: A total of 516 women from the 5 geographic regions of Brazil were included. Participants were interviewed with a structured questionnaire for assessment of milk and/or dairy intake. Vaginal samples were used for sequencing of V3-V4 regions of the 16S ribosomal RNA gene for further determination of L. crispatus relative abundance (RA) and clustering into 1 of the 5 CSTs (CSTI-CSTV), as firstly described by Ravel et al. (2011). The nonparametric Mann-Whitney test was used to compare L. crispatus RA within the most representative CSTs ( L. crispatus -dominant CSTI, Lactobacillus iners -dominant CSTIII, and Lactobacillus -depleted CSTIV) in this population, according to the frequency of milk and/or dairy intake.
Results: The prevalence of CSTI was 33.3% ( n = 172), CSTIII was 39% ( n = 201), and CSTIV was 27.7% ( n = 143). Among the participants with CSTIII, higher L. crispatus RA was observed for those who reported milk/dairy intake (median = 0.02; interquartile range = 0.01-0.09) than those with no consumption (median = 0.01; interquartile range = 0-0.03) ( p = .03). Such difference was not observed for participants with CSTI and CSTIV.
Conclusions: Women with vaginal microbiota dominated by L. iners who consume milk and/or dairy present increased abundances of L. crispatus . Therefore, they could benefit from L. crispatus protective properties conferring greater temporal microbiota stability and, consequently, increased protection against infections.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus crispatus | Increased Abundance of Lactobacillus Crispatus | Beneficial | Moderate |
Lactobacillus crispatus LCr86 | Improved Stability of Gut Microbiota | Beneficial | Moderate |
Lactobacillus crispatus LCr86 | Increased Abundance of Lactobacillus Crispatus | Beneficial | Moderate |
Lactobacillus crispatus LV5 88 | Increased Abundance of Lactobacillus Crispatus | Beneficial | Moderate |
Lactobacillus crispatus UALcr-35 | Improved Infection Protection | Beneficial | Moderate |
Lactobacillus crispatus UALcr-35 | Improved Stability of Gut Microbiota | Beneficial | Moderate |
Lactobacillus crispatus UALcr-35 | Increased Abundance of Lactobacillus Crispatus | Beneficial | Moderate |